Back to BAKER BROS. ADVISORS LP

KNSA
8 quarters

Position history for BAKER BROS. ADVISORS LP's holdings in KINIKSA PHARMACEUTICALS INTL

BAKER BROS. ADVISORS LP holds 2.8M shares of KNSA (KINIKSA PHARMACEUTICALS INTL), worth $136.1M as of 2026-Q1. KNSA represents 0.8% of BAKER BROS. ADVISORS LP's portfolio.

Current Value

$136.1M

Current Shares

2.8M

Total Value Change

+$83.5M

Total Shares Change

+7,923

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
2.8M
0.0%
$136.1M0.8%$45.37
0
2025-Q4
Increased
2.8M
+0.1%
$116.6M0.7%$40.99
42
2025-Q3
Unchanged
2.8M
0.0%
$109.7M0.8%$38.77
0
2025-Q2
Increased
2.8M
+0.2%
$78.2M0.8%$28.04
42
2025-Q1
Unchanged
2.8M
0.0%
$62.6M0.7%$23.09
0
2024-Q4
Unchanged
2.8M
0.0%
$55.7M0.6%$19.60
0
2024-Q3
Unchanged
2.8M
0.0%
$70.4M0.7%$25.00
0
2024-Q2
New
2.8M
-
$52.6M0.7%$18.67
57

Other major holders of KNSA: FMR LLC, VANGUARD GROUP INC, BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used